Images |
Sources |
Experiment + Assay |
Phenotypes |
Human Diseases |
|
Fig. S3 GHI
Azbazdar Y and De Robertis EM (2024)
|
Xla Wt + ctnnb1 MO
NF13 (RT-PCR)
|
|
|
|
Fig. 3
Virgirinia RP et al. (2021)
|
Xla Wt + clk1
NF21 (RT-PCR)
|
|
|
|
Fig. 3
Virgirinia RP et al. (2021)
|
Xla Wt + clk3
NF21 (RT-PCR)
|
|
|
|
Fig. 4 FGH
Virgirinia RP et al. (2021)
|
Xtr Wt + clk3 MO
NF37/38 (qPCR)
|
|
|
|
Fig. 4 C lane 3
Lichtig H et al. (2020)
|
Xla + asxl3 MO
NF16 (RT-PCR)
|
|
|
|
Fig. 4 A lane 5
Lichtig H et al. (2020)
|
Xla Wt + asxl3 MO + animal cap amputation
NF16 (RT-PCR)
|
|
|
|
Fig. 4 B lane 6
Lichtig H et al. (2020)
|
Xla Wt + asxl3 MO + animal cap amputation
NF16 (RT-PCR)
|
|
|
|
Fig.3.C
Iwasaki Y and Thomsen GH (2014)
|
Xla Wt + pqbp1 MO
NF28 (in situ hybridization)
|
|
Renpenning syndrome
|
|
Fig 4. B
Nieber F et al. (2013)
|
Xla Wt + numbl MO
NF15 (in situ hybridization)
|
|
|
|
fig.7.d
Mir A et al. (2007)
|
Xla Wt + dnbmp7.1 + animal cap explant
NF14 (RT-PCR)
|
|
|